Healthcare Industry News: cryoablation
News Release - March 1, 2016
Endocare Announces Signing Of Exclusive Agreement With R-Action DistributionAUSTIN, Texas and NYON, Switzerland, March 1, 2016 -- (Healthcare Sales & Marketing Network) -- Endocare, Inc announced today the signing of an exclusive agreement with R-Action Distribution Sārl, a subsidiary of R-Action SAS, for the distribution of its Endocare cryoablation technology in France and Switzerland coinciding with a first installation at Institut Mutualiste Montsouris in Paris, France.
Endocare cryoablation therapy is a specialized type of cryotherapy for the minimally invasive treatment of cancer of the prostate, kidney and lung as well as liver metastases and palliative intervention. Prostate salvage cryotherapy is a form of treatment administered when radiation therapy has not been successful and a growing amount of evidence supports the use of cryotherapy for patients with localized prostate cancer following radiation therapy (Jones JS. European Urology 2011; 60:411-412).
Utilization of cryotherapy for the treatment of small tumors of the kidney has also increased in recent years due to the fact that, in addition to urologic cryosurgeons, interventional radiologists can perform cryotherapy with high precision using computerized tomography (CT) scanning under either general anesthesia or conscious sedation.
Endocare, Inc is a subsidiary of HealthTronics, Inc. dedicated to treating cancer with innovative minimally invasive approaches. The current core of its technologies is cryoablation for destruction of tumors in the kidney and lung as well as treating prostate cancer, liver metastases and providing palliative intervention for cancer.
ENDOCARE is a trademark of Endocare, Inc, registered in the U.S. and other countries.
About R-Action Distribution
R-Action Distribution Sārl is a manufacturer and distributor of medical devices for use in urology, coloproctology, OB/GYN, paediatric and general surgery.
R-Action Distribution represents leading North American and European manufacturers through direct operations in Switzerland, France, Germany, Austria, the Benelux countries and a joint venture in Russia.
Source: R-Action Distribution
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.